Asia-Pacific Point-Of-Care Diagnostics Market By Product (Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, Drugs Of Abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry, Others), By End-Users (Clinics, Hospitals, Home Healthcare, Ambulatory Care Settings, Laboratories, Others), By Mode Of Delivery (OTC, Prescription) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia-Pacific Point-Of-Care Diagnostics Market By Product (Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, Drugs Of Abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry, Others), By End-Users (Clinics, Hospitals, Home Healthcare, Ambulatory Care Settings, Laboratories, Others), By Mode Of Delivery (OTC, Prescription) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 1562 | Pages: 143 | November 2016 | Region: Asia Pacific


Asia-Pacific Point-of-care Diagnostics Market was worth $3.01 billion in 2016 and estimated to reach $4.92 billion by the end of 2021 with a CAGR of 10.28%. Point-of-care diagnostics allow a speedy, convenient, and cost-efficient way to diagnose diseases at healthcare centers and hospitals. Point-of-care diagnostics is a term collectively used for diagnostic procedures and tests performed on-site. As compared to conventional in-laboratory tests, point-of-care diagnostics have the advantage of speed and convenience without compromising on consistency. Point-of-care diagnostics help cut down on the need for sophisticated diagnostic systems for regular tests like blood tests and urine tests.

Many advanced point of care diagnostic products are on the verge of being used practically and widely. But, more than innovative and advanced point-of-care devices, there is an extensive need for inexpensive solutions that can be set up in regions where infectious diseases are highly prevalent. In developing regions, these tests are crucial in counterbalancing the lack of adequate laboratory capacity. This is one of the most promising opportunities that can be grabbed by market players.

In order to provide effective and fast diagnostic results, clinics and other healthcare establishments, are opting for point-of-care test, which are consequently influencing industrial growth. Advances in technology and introduction of cost effective and high quality medical solutions aimed at achieving miniaturization and lab automation are expected to serve the point-of-care diagnostics market as a vital driver. Additionally, healthcare practitioners have been observed to be increasingly more open and willing to adopt the use of point-of-care diagnostic consumables and medical devices thereby resulting in rapid demand and growth of this market. However, there are some certain market restraints that players need to overcome. The effort and co-ordination required among healthcare centers, researchers, practitioners and manufacturers is the greatest restraining factor for the growth of point-of-care diagnostics market. Also, reluctance from the industry towards changing the existing norms, frequent product recalls, stringent regulatory framework and unfavorable reimbursement scenario are some of the challenges faced by the point-of-care diagnostics market.

The Asia-Pacific point-of-care diagnostics market is segmented based on products, end-users and mode of delivery. Products have been segmented into Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, drugs of abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry and others. By End-Users, the market has been further segmented as clinics, hospitals, home healthcare, ambulatory care settings, laboratories and others. Finally on the basis of delivery, the market has been segmented further into OTC and prescription modes of delivery.

On the basis of geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Emerging markets such as China and India offer high growth potential for companies involved in the development and distribution of point-of-care diagnostic devices. Increasing initiatives by market players, growing patient population base, and rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of point-of-care diagnostics market in emerging countries.

Some of the major players in this market are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson , Alere Inc., and PTS Diagnostics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Infectious Diseases Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Cardiac Markers Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Oncology Markers Market By Region, From 2016-2021 ( USD Billion )
  5. Asia-Pacific OTC Diagnostic Tests Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Drugs Of Abuse Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Blood Gas Testing Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Fertility Testing Market By Region, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Urinalysis Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Coagulation Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Hematology Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Glucose Monitoring Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Ambulatory Chemistry Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific Decentralized Clinical Chemistry Market By Region, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  17. Asia-Pacific Clinics Market By Region, From 2016-2021 ( USD Billion )
  18. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Billion )
  19. Asia-Pacific Home Healthcare Market By Region, From 2016-2021 ( USD Billion )
  20. Asia-Pacific Ambulatory Care Settings Market By Region, From 2016-2021 ( USD Billion )
  21. Asia-Pacific Laboratories Market By Region, From 2016-2021 ( USD Billion )
  22. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Billion )
  23. Asia-Pacific Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
  24. Asia-Pacific OTC Market By Region, From 2016-2021 ( USD Billion )
  25. Asia-Pacific Prescription Market By Region, From 2016-2021 ( USD Billion )
  26. Japan Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  27. Japan Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  28. Japan Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
  29. China Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  30. China Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  31. China Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
  32. India Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  33. India Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  34. India Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
  35. Australia Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  36. Australia Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  37. Australia Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
  38. South Korea Point-of-Care Diagnostics Market By Application, From 2016-2021 ( USD Billion )
  39. South Korea Point-of-Care Diagnostics Market By End-Users, From 2016-2021 ( USD Billion )
  40. South Korea Point-of-Care Diagnostics Market By Mode of Delivery, From 2016-2021 ( USD Billion )
Middle-East And Africa Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], ...
Latin America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Asia-Pacific Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (...
Europe Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharma...
North America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharmaceutica...
Middle East And Africa Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid T...
Latin America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And ...
Europe Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others...
North America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others) And B...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.